Intratumoral Heterogeneity in Lung Cancer

被引:6
|
作者
Lv, Xiaodi [1 ]
Mao, Zixian [2 ]
Sun, Xianjun [1 ,3 ]
Liu, Baojun [1 ,3 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Integrat Med, Shanghai 200437, Peoples R China
[2] Pujiang Community Hlth Ctr Minhang Dist Shanghai, Shanghai 201114, Peoples R China
[3] Fudan Univ, Inst Integrat Med, Shanghai 200437, Peoples R China
基金
中国国家自然科学基金;
关键词
intratumoral heterogeneity; lung cancer; space and time; therapeutic strategy; TUMOR HETEROGENEITY; GLUCOSE-METABOLISM; CELL HETEROGENEITY; MUTATION STATUS; KRAS MUTATION; RESISTANCE; EXPRESSION; RECEPTOR; EVOLUTION; GROWTH;
D O I
10.3390/cancers15102709
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The diagnosis and treatment of lung cancer (LC) is always a challenge. The difficulty in the decision of therapeutic schedule and diagnosis is directly related to intratumoral heterogeneity (ITH) in the progression of LC. It has been proven that most tumors emerge and evolve under the pressure of their living microenvironment, which involves genetic, immunological, metabolic, and therapeutic components. While most research on ITH revealed multiple mechanisms and characteristic, a systemic exposition of ITH in LC is still hard to find. In this review, we describe how ITH in LC develops from the perspective of space and time. We discuss elaborate details and affection of every aspect of ITH in LC and the relationship between them. Based on ITH in LC, we describe a more accurate multidisciplinary therapeutic strategy on LC and provide the newest opinion on the potential approach of LC therapy.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
    Nino, Jorge Luis Galeano
    Wu, Hanrui
    LaCourse, Kaitlyn D.
    Kempchinsky, Andrew G.
    Baryiames, Alexander
    Barber, Brittany
    Futran, Neal
    Houlton, Jeffrey
    Sather, Cassie
    Sicinska, Ewa
    Taylor, Alison
    Minot, Samuel S.
    Johnston, Christopher D.
    Bullman, Susan
    NATURE, 2022, 611 (7937) : 810 - +
  • [42] Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases
    Christensson, Gustav
    Bocci, Matteo
    Kazi, Julhash U.
    Durand, Geoffroy
    Lanzing, Gustav
    Pietras, Kristian
    Velozo, Hugo Gonzalez
    Hagerling, Catharina
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (11): : 2888 - 2902
  • [43] Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
    Jia, Qingzhu
    Wu, Wei
    Wang, Yuqi
    Alexander, Peter B.
    Sun, Chengdu
    Gong, Zhihua
    Cheng, Jia-Nan
    Sun, Huaibo
    Guan, Yanfang
    Xia, Xuefeng
    Yang, Ling
    Yi, Xin
    Wan, Yisong Y.
    Wang, Haidong
    He, Ji
    Futreal, P. Andrew
    Li, Qi-Jing
    Zhu, Bo
    NATURE COMMUNICATIONS, 2018, 9
  • [44] Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer
    Traynor, Sofie
    Jakobsen, Mie K.
    Green, Tina M.
    Komic, Hana
    Palarasah, Yaseelan
    Pedersen, Christina B.
    Ditzel, Henrik J.
    Thoren, Fredrik B.
    Guldberg, Per
    Gjerstorff, Morten F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [45] Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer
    Yang, Fei
    Thomas, Maria A.
    Dehdashti, Farrokh
    Grigsby, Perry W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) : 716 - 727
  • [46] Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
    Qazi, M. A.
    Vora, P.
    Venugopal, C.
    Sidhu, S. S.
    Moffat, J.
    Swanton, C.
    Singh, S. K.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1448 - 1456
  • [47] Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis
    Schallenberg, Simon
    Dragomir, Mihnea-Paul
    Anders, Philipp
    Ebner, Benedikt
    Volz, Yannic
    Eismann, Lennert
    Rodler, Severin
    Casuscelli, Jozefina
    Buchner, Alexander
    Klauschen, Frederick
    Stief, Christian
    Horst, David
    Schulz, Gerald Bastian
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 788 - 798
  • [48] Resistance to neoadjuvant chemotherapy in breast cancer with proven intratumoral heterogeneity: a clinical case
    Nanev, Vasil D.
    Naneva, Silvia, V
    Yordanov, Angel D.
    Strashilov, Strahil A.
    Ivanov, Ivan N.
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (02): : 134 - 138
  • [49] Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer
    Vlajnic, Tatjana
    Mueller, David C.
    Ruiz, Christian
    Schonegg, Rene
    Seifert, Hans-Helge
    Thalmann, George N.
    Zellweger, Tobias
    Le Magnen, Clementine
    Rentsch, Cyrill A.
    Bubendorf, Lukas
    CANCER REPORTS, 2024, 7 (02)
  • [50] A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity
    Simpson, Kathryn L.
    Stoney, Ruth
    Frese, Kristopher K.
    Simms, Nicole
    Rowe, William
    Pearce, Simon P.
    Humphrey, Sam
    Booth, Laura
    Morgan, Derrick
    Dynowski, Marek
    Trapani, Francesca
    Catozzi, Alessia
    Revill, Mitchell
    Helps, Thomas
    Galvin, Melanie
    Girard, Luc
    Nonaka, Daisuke
    Carter, Louise
    Krebs, Matthew G.
    Cook, Natalie
    Carter, Mathew
    Priest, Lynsey
    Kerr, Alastair
    Gazdar, Adi F.
    Blackhall, Fiona
    Dive, Caroline
    NATURE CANCER, 2020, 1 (04) : 437 - +